Assessing the effect of clonidine(antihypertensive drug) in reducing the increase in heart rate and blood pressure during electroconvulsive therapy
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037481
- Lead Sponsor
- Vigneshwaran S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients undergoing modified ECT belonging to ASA class 1 and 2
Exclusion Criteria
Patients belonging to ASA class 3 and 4,
patients with ischemic heart disease, cardiac arrythmias, uncontrolled hypertension, history of stroke within one year, renal and hepatic dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the efficacy of premedication with intravenous clonidine in attenuating hemodynamic response ( Heart rate, Systolic, diastolic and mean blood pressures)Timepoint: baseline (just before premedication), just before induction of anesthesia, just before administration of ECT, and post ECT at 2, 4, 6, 8, 10, 15, 20, 30, 45 minutes and at 1, 1.5 and 2 hours
- Secondary Outcome Measures
Name Time Method To determine the efficacy of premedication with intravenous clonidine in the prevention of post ECT agitation using Richmond agitation - sedation scaleTimepoint: Post ECT every 5 minutes upto 1 hour and then every 15 minutes during second hour